专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20100311835A1 CIS-9, TRANS-11 ISOMER OF CONJUGATED LINOLEIC ACID (CLA) FOR TREATING INFLAMMATORY DISEASES 审中-公开
标题翻译： CIS-9，TRANS-11异烟肼（CLA）用于治疗炎症性疾病
公开(公告)号：US20100311835A1
公开(公告)日：2010-12-09
申请号：US12701971
申请日：2010-02-08
申请人： Doris Bell , Albrecht Weiss , Albert Strube , Bernd Fabry , Gerhard Jahreis , Anke Jaudszus
发明人： Doris Bell , Albrecht Weiss , Albert Strube , Bernd Fabry , Gerhard Jahreis , Anke Jaudszus
IPC分类号： A61K31/201 , A61P11/06 , A61P11/00
CPC分类号： A61K31/201
摘要： A composition and medicament comprising the cis-9, trans-11 isomer of conjugated linoleic acid for treating inflammatory diseases, including asthma, is provided. A method for inhibiting the proliferation of human or animal cells of the immune systems involved in an immune response including administering the cis-9, trans-11 isomer of conjugated linoleic acid to a patient is also provided. A nutritional, functional food, or dietary supplement including the cis-9, trans-11 isomer of conjugated linoleic acid is also provided.
摘要翻译：提供了包含用于治疗炎症性疾病（包括哮喘）的共轭亚油酸的顺式-9反式-11异构体的组合物和药物。还提供了抑制涉及免疫应答的免疫系统的人或动物细胞增殖的方法，包括向患者施用共轭亚油酸的顺式-9反式-11异构体。还提供了营养功能食品或膳食补充剂，包括共轭亚油酸的顺式-9反式-11异构体。

2. 发明授权

US07604966B2 Process for the production of structured lipid mixtures 有权
标题翻译：生产结构化脂质混合物的方法
公开(公告)号：US07604966B2
公开(公告)日：2009-10-20
申请号：US11554799
申请日：2006-10-31
申请人： Ulrich Schoerken , Doris Bell , Peter Horlacher , Diana Stuhlmann , Carolin Meyer
发明人： Ulrich Schoerken , Doris Bell , Peter Horlacher , Diana Stuhlmann , Carolin Meyer
IPC分类号： C12P7/64
CPC分类号： C11C3/10 , A21D2/165 , A23D9/00 , A23K20/158 , A23L33/115 , A23L33/12
摘要： The invention relates to structured lipid mixtures corresponding to formula (I): characterized in that R1CO, R2CO and R3CO independently of one another represent (i) linear saturated acyl groups containing 6 to 12 carbon atoms or (ii) the acyl group of conjugated linoleic acid (CLA) and/or an omega-3 or omega-6 fatty acid (OF), with the proviso that the quantity of CLA acyl groups amounts to 3 to 50 mol- % and the quantity of OF acyl groups to 5 to 25 mol- %, based on the quantity of acyl groups. The mixtures are preferably made by subjecting a mixture of component (a) a medium-chain triglyceride; and component (b) a CLA, an (OF), a TG-CLA (TG-OF) or a mixture thereof to enzymatic transesterification in the presence of a vegetable, marine or microbial oil.
摘要翻译：本发明涉及对应于式（I）的结构化脂质混合物：其特征在于R1CO，R2CO和R3CO彼此独立地表示（i）含有6至12个碳原子的直链饱和酰基或（ii）共轭亚油酸的酰基酸（CLA）和/或ω-3或ω-6脂肪酸（OF），条件是CLA酰基的量为3〜50摩尔％，酰基的量为5〜25 mol％，基于酰基的数量。混合物优选通过将组分（a），中链甘油三酯的混合物，和（b）CLA，（OF），TG-CLA（TG-OF）或其混合物在植物，海洋或微生物油的存在下进行酶促酯交换反应。

3. 发明授权

US08329672B2 Oral and/or topical compositions comprising prebiotics and fatty acid 有权
标题翻译：包含益生元和脂肪酸的口服和/或局部组合物
公开(公告)号：US08329672B2
公开(公告)日：2012-12-11
申请号：US11597776
申请日：2005-05-14
申请人： Santiago Rull Prous , Bernd Fabry , José Blasquez Fernandez , Doris Bell
发明人： Santiago Rull Prous , Bernd Fabry , José Blasquez Fernandez , Doris Bell
IPC分类号： A01N43/04 , A61K31/715
CPC分类号： A23L33/21 , A23L33/12 , A23L33/135 , A23L33/20 , A23V2002/00 , A23V2250/5062 , A23V2250/1872 , A23V2250/187 , A23V2250/1868 , A23V2250/5034
摘要： Compositions for oral and/or topical administration of a prebiotic and a physiologically active fatty acid, or a salt or ester thereof, are disclosed. The compositions are disclosed as enhancing the body's population of beneficial microorganisms for improving health and well-being.
摘要翻译：公开了用于口服和/或局部施用益生元和生理活性脂肪酸或其盐或酯的组合物。所述组合物被公开为增强人体的有益微生物群体以改善健康和福祉。

4. 发明申请

US20080268024A1 Compositions for Oral and/or Topical Administration 审中-公开
标题翻译：口头和/或专题管理的组成
公开(公告)号：US20080268024A1
公开(公告)日：2008-10-30
申请号：US11569615
申请日：2005-05-14
申请人： Santiago Rull Prous , Bernd Fabry , Doris Bell
发明人： Santiago Rull Prous , Bernd Fabry , Doris Bell
IPC分类号： A61K47/10 , A61P1/00
CPC分类号： A61K36/63 , A23L33/105 , A23L33/20 , A23L33/21 , A23P10/30 , A23V2002/00 , A61K31/35 , A61K31/702 , A61K31/716 , A61K36/16 , A61K36/185 , A61K36/48 , A61K36/77 , A61K36/82 , A61K45/06 , A61K2300/00 , A23V2250/2116 , A23V2200/3202 , A23V2250/2132 , A23V2250/21 , A23V2250/5062 , A23V2250/28
摘要： Compositions for oral and/or topical administration of a prebiotic and a polyphenol or a plant extract containing a polyphenol, and mixtures thereof, are disclosed. The compositions are disclosed as enhancing the body's population of beneficial microorganisms for improving health and well-being.
摘要翻译：公开了用于口服和/或局部施用益生元和多酚或含有多酚的植物提取物的组合物及其混合物。所述组合物被公开为增强人体的有益微生物群体以改善健康和福祉。

5. 发明申请

US20080241263A1 Oral and/or Topical Compositions Comprising Prebiotics and Sterols 审中-公开
标题翻译：包含益生元和固醇的口服和/或局部组合物
公开(公告)号：US20080241263A1
公开(公告)日：2008-10-02
申请号：US11597647
申请日：2005-05-14
申请人： Santiago Rull Prous , Bernd Fabry , Doris Bell
发明人： Santiago Rull Prous , Bernd Fabry , Doris Bell
IPC分类号： A61K9/14 , A61P17/00
CPC分类号： A23L33/21 , A23L27/34 , A23L33/11 , A23L33/12 , A23L33/20 , A23V2002/00 , A23V2250/5062 , A23V2250/21372 , A23V2250/2137 , A23V2250/28 , A23V2250/5034
摘要： Compositions for oral and/or topical administration of a prebiotic and a sterol or an ester thereof are disclosed. The compositions are disclosed as enhancing the body's population of beneficial microorganisms for improving health and well-being.
摘要翻译：公开了用于口服和/或局部施用益生元和甾醇或其酯的组合物。所述组合物被公开为增强人体的有益微生物群体以改善健康和福祉。

6. 发明申请

US20080193406A1 Oral and/or Topical Compositions Comprising Prebiotics and Fatty Acid 有权
标题翻译：包含益生元和脂肪酸的口服和/或局部组合物
公开(公告)号：US20080193406A1
公开(公告)日：2008-08-14
申请号：US11597776
申请日：2005-05-14
申请人： Santiago Rull Prous , Bernd Fabry , Jose Blasquez Fernandez , Doris Bell
发明人： Santiago Rull Prous , Bernd Fabry , Jose Blasquez Fernandez , Doris Bell
IPC分类号： A61K31/00 , A23L1/48 , A61K31/7016 , A61K31/702 , A61K31/715 , A61K31/716 , A61K31/733
CPC分类号： A23L33/21 , A23L33/12 , A23L33/135 , A23L33/20 , A23V2002/00 , A23V2250/5062 , A23V2250/1872 , A23V2250/187 , A23V2250/1868 , A23V2250/5034
摘要： Compositions for oral and/or topical administration of a prebiotic and a physiologically active fatty acid, or a salt or ester thereof, are disclosed. The compositions are disclosed as enhancing the body's population of beneficial microorganisms for improving health and well-being.
摘要翻译：公开了用于口服和/或局部施用益生元和生理活性脂肪酸或其盐或酯的组合物。所述组合物被公开为增强人体的有益微生物群体以改善健康和福祉。

7. 发明授权

US06566304B1 Biogenic control and limitation of the reproduction of parasitic earth nematodes in stock culture 失效
标题翻译：生物控制和限制寄生的地球线虫在库存培养中的繁殖
公开(公告)号：US06566304B1
公开(公告)日：2003-05-20
申请号：US09701599
申请日：2001-02-06
申请人： Doris Bell , Bettina Kopp-Holtwiesche , Stephan Von Tapavicza
发明人： Doris Bell , Bettina Kopp-Holtwiesche , Stephan Von Tapavicza
IPC分类号： A01N4728
CPC分类号： C05G3/06 , A47B2200/0023 , C05B15/00 , Y10S71/903 , C05C9/00
摘要： The invention relates to use of (a) compounds of phosphorus containing at least partly lipophilic organic radicals together with (b) urea and/or urea derivatives in selected quantity ratios of (a) to (b) as a soil additive for biologically controlling plant-parasitic soil nematodes by strengthening the correspondingly antagonistic soil potential, more particularly by strengthening the growth of antagonistic and/or nematicidal rhizosphere bacteria and/or corresponding mycorrhiza strains—and at the same time strengthening the growth of cultivated plants in soil. The multicomponent mixtures which strengthen bacterial growth are preferably introduced into the region of the plant roots in the form of an aqueous preparation using plant-compatible emulsifiers before and/or during plant growth. Components (a) and (b) are used in such quantity ratios that the ratio by weight of C to N is no higher than 6:1 and preferably no higher than 5:1.
摘要翻译：本发明涉及（a）含有至少部分亲脂性有机基团的磷化合物与（b）选择量比例的（a）至（b）的脲和/或脲衍生物的化合物作为生物控制植物的土壤添加剂通过加强对应的土壤潜力，特别是通过加强拮抗和/或杀线虫根际细菌和/或相应的菌根菌株的生长，同时加强土壤中栽培植物的生长，从而增强土壤线虫。加强细菌生长的多组分混合物优选在植物生长之前和/或植物生长期间以植物相容的乳化剂以水性制剂的形式引入植物根的区域。组分（a）和（b）以这样的数量比例使用，即C与N的重量比不高于6:1，优选不高于5:1。

8. 发明申请

US20050222259A1 Methods of activating PPAR-alpha nuclear receptors in mammals 审中-公开
标题翻译：激活哺乳动物PPAR-α核受体的方法
公开(公告)号：US20050222259A1
公开(公告)日：2005-10-06
申请号：US11074953
申请日：2005-03-07
申请人： Doris Bell , Ralf Zink , Albrecht Weiss
发明人： Doris Bell , Ralf Zink , Albrecht Weiss
IPC分类号： A23D9/00 , A23K1/16 , A23L1/30 , A61K31/00 , A61K31/201 , A61K45/00 , A61P3/04 , A61P43/00 , A61K31/202
CPC分类号： A61K31/201 , A23D9/00 , A23K20/158 , A23L33/12 , A61K31/00 , A61K2300/00
摘要： The use of a composition comprising an unsaturated fatty acid which activates the nuclear receptor PPAR-alpha for the manufacture of a dietary supplement, a functional food, or a medicament for reducing appetite or food intake is disclosed. The preferred substances are conjugated fatty acids especially conjugated linoleic acid.
摘要翻译：公开了使用包含不饱和脂肪酸的组合物，其活化核受体PPAR-α以制备膳食补充剂，功能性食品或用于减少食欲或食物摄取的药物。优选的物质是共轭脂肪酸，尤其是共轭亚油酸。

9. 发明申请

US20070111292A1 STRUCTURED LIPID MIXTURES 有权
标题翻译：结构脂肪混合物
公开(公告)号：US20070111292A1
公开(公告)日：2007-05-17
申请号：US11554799
申请日：2006-10-31
申请人： Ulrich Schoerken , Doris Bell , Peter Horlacher , Diana Stuhlmann , Carolin Meyer
发明人： Ulrich Schoerken , Doris Bell , Peter Horlacher , Diana Stuhlmann , Carolin Meyer
IPC分类号： A61K31/22 , C12P7/64
CPC分类号： C11C3/10 , A21D2/165 , A23D9/00 , A23K20/158 , A23L33/115 , A23L33/12
摘要： The invention relates to structured lipid mixtures corresponding to formula (I): characterized in that R1CO, R2CO and R3CO independently of one another represent (i) linear saturated acyl groups containing 6 to 12 carbon atoms or (ii) the acyl group of conjugated linoleic acid (CLA) and/or an omega-3 or omega-6 fatty acid (OF), with the proviso that the quantity of CLA acyl groups amounts to 3 to 50 mol-% and the quantity of OF acyl groups to 5 to 25 mol-%, based on the quantity of acyl groups. The mixtures are preferably made by subjecting a mixture of component (a) a medium-chain triglyceride; and component (b) a CLA, an (OF), a TG-CLA (TG-OF) or a mixture thereof to enzymatic transesterification in the presence of a vegetable, marine or microbial oil.
摘要翻译：本发明涉及对应于式（I）的结构化脂质混合物：其特征在于R 1 CO，R 2 CO和R 3 CO独立地彼此表示（i）含有6至12个碳原子的直链饱和酰基或（ii）共轭亚油酸（CLA）和/或ω-3或ω-6脂肪酸（OF）的酰基，其中条件是基于酰基的量，CLA酰基的量为3至50摩尔％，酰基的量为5至25摩尔％。混合物优选通过将组分（a），中链甘油三酯的混合物，和（b）CLA，（OF），TG-CLA（TG-OF）或其混合物在植物，海洋或微生物油的存在下进行酶促酯交换反应。

10. 发明申请

US20090118369A1 Use of CIS-9, Trans-11 Isomer of Conjugated Lineoleic Acid 审中-公开
标题翻译： CIS-9，共轭异戊二烯酸异构体的使用
公开(公告)号：US20090118369A1
公开(公告)日：2009-05-07
申请号：US10565135
申请日：2003-12-19
申请人： Doris Bell , Albrecht Weiss , Albert Strube , Bernd Fabry , Gerhard Jahreis , Anke Jaudszus
发明人： Doris Bell , Albrecht Weiss , Albert Strube , Bernd Fabry , Gerhard Jahreis , Anke Jaudszus
IPC分类号： A61K31/19 , A61P29/00 , A61P11/00
CPC分类号： A61K31/201
摘要： A composition and medicament comprising the cis-9, trans-11 isomer of conjugated linoleic acid for treating inflammatory diseases, including asthma, is provided. A method for inhibiting the proliferation of human or animal cells of the immune systems involved in an immune response including administering the cis-9, trans-11 isomer of conjugated linoleic acid to a patient is also provided. A nutritional, functional food, or dietary supplement including the cis-9, trans-11 isomer of conjugated linoleic acid is also provided.
摘要翻译：提供了包含用于治疗炎症性疾病（包括哮喘）的共轭亚油酸的顺式-9反式-11异构体的组合物和药物。还提供了抑制涉及免疫应答的免疫系统的人或动物细胞增殖的方法，包括向患者施用共轭亚油酸的顺式-9反式-11异构体。还提供了营养功能食品或膳食补充剂，包括共轭亚油酸的顺式-9反式-11异构体。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式